CND Life Sciences
PrivateLast Round
Seed Round
Jun 16, 2026
Total Funding Raised
$34.72M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CND Life Sciences is a biotechnology company that provides a diagnostic test to aid in the confirmation of synucleinopathies like Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CND Life Sciences Comparables
Compare CND Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sunbird Bio | 79% | |
| SYNAPS Dx | 74% | |
| Amprion | 74% |
CND Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 16, 2026 | ||||
| Grant | Oct 22, 2025 | ||||
| Series A | May 1, 2025 | ||||
| Grant | Nov 20, 2024 | ||||
| Grant | May 1, 2023 | ||||
Grant | May 18, 2022 |
Key People
Founding team and executive leadership
CND Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VILAS Ventures | Series A |
| Top Corner Capital | Series A, Grant |
| Lupo Labs | Series A |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cambrian Growth Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Raised $4.3M in Seed funding.
- Oct 22, 2025
Secured $3M in grant funding.
Recent news
Latest coverage and updates
- expands_facilitiesSep 18, 2026
CND Life Sciences, Inc. expanded facilities to Scottsdale, Arizona, United States, Northern America, Americas on Sep 17th '26.
- expands_facilitiesSep 17, 2026
CND Life Sciences, Inc. expanded facilities to Arizona, United States, Northern America, Americas on Sep 17th '26.
CND Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CND Life Sciences's valuation, stock price, and market status.
Is CND Life Sciences a public or private company?
CND Life Sciences is a private company.
What is the current stock price of CND Life Sciences?
CND Life Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is CND Life Sciences worth (valuation)?
Valuation information for CND Life Sciences is not publicly available.
Can I buy CND Life Sciences stock?
CND Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CND Life Sciences's last funding round?
CND Life Sciences's most recent funding round was Seed Round on June 16, 2026.
Who are the main investors in CND Life Sciences?
Key investors in CND Life Sciences include VILAS Ventures, Top Corner Capital, NIH RADx, Cambrian Growth Partners, Tanis Ventures.
Will CND Life Sciences IPO soon?
No public IPO plans have been announced for CND Life Sciences.
How can I track CND Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CND Life Sciences's secondary market activity and sign up for updates.